• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Retinoblastoma: survival, age at detection and comparison 1914-1958, 1958-1983.

作者信息

Abramson D H, Ellsworth R M, Grumbach N, Kitchin F D

出版信息

J Pediatr Ophthalmol Strabismus. 1985 Nov-Dec;22(6):246-50. doi: 10.3928/0191-3913-19851101-11.

DOI:10.3928/0191-3913-19851101-11
PMID:4078667
Abstract

A retrospective analysis of the records of 1531 retinoblastoma patients (809 male, 720 female, sex of two not known) was carried out to ascertain life table survivals. Of patients seen between 1914 and 1983 survival from metastatic retinoblastoma was the same for unilateral and bilateral patients. Metastatic retinoblastoma occurred within four years from diagnosis of the unilaterally affected patients and within nine years from diagnosis of the bilaterally affected patients. Survival thereafter remained at 76%. Because of the development of second non-ocular tumors in survivors of bilateral retinoblastoma there was a dramatic difference between survival of the patient with unilateral and bilateral disease. Within five years after diagnosis of bilateral retinoblastoma more children die from their second tumor than retinoblastoma itself. By 25 years after diagnosis more than 50% of the bilaterally affected children are dead and by 35 years 59% are dead. There was no difference between survival of boys and girls. Although bilateral patients were seen at significantly lower ages at diagnosis, they did not have a lower mortality rate from metastatic retinoblastoma. Despite the fact that bilaterally affected children with a family history were diagnosed at a younger age than those without a family history (11 vs. 15 mos.) mortality from metastatic retinoblastoma was the same. Similarly, even though unilateral patients with a family history were diagnosed younger than those without a family history (5 vs. 25 mos.) mortality from metastatic retinoblastoma was the same. There has been little change in the age at detection for retinoblastoma in the pre- versus post-1958 series and no change in survival rate for bilateral or unilateral patients.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Retinoblastoma: survival, age at detection and comparison 1914-1958, 1958-1983.
J Pediatr Ophthalmol Strabismus. 1985 Nov-Dec;22(6):246-50. doi: 10.3928/0191-3913-19851101-11.
2
Retinoblastoma: correlation between age at diagnosis and survival.
J Pediatr Ophthalmol Strabismus. 1986 Jul-Aug;23(4):174-7. doi: 10.3928/0191-3913-19860701-06.
3
Parents with unilateral retinoblastoma: their affected children.
Br J Ophthalmol. 1996 Mar;80(3):197-9. doi: 10.1136/bjo.80.3.197.
4
(Neonatal) retinoblastoma in the first month of life.出生后第一个月内的(新生儿)视网膜母细胞瘤。
Arch Ophthalmol. 2002 Jun;120(6):738-42. doi: 10.1001/archopht.120.6.738.
5
Retrospective analysis of 58 children with retinoblastoma.
Ophthalmic Paediatr Genet. 1984 Aug;4(2):67-74. doi: 10.3109/13816818409007840.
6
Survival in extra-orbital metastatic retinoblastoma:treatment results.眶外转移性视网膜母细胞瘤的生存情况:治疗结果
Clin Transl Oncol. 2006 Jan;8(1):39-44. doi: 10.1007/s12094-006-0093-x.
7
Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?视网膜母细胞瘤幸存者中的第二种非眼部肿瘤。它们是辐射诱发的吗?
Ophthalmology. 1984 Nov;91(11):1351-5. doi: 10.1016/s0161-6420(84)34127-6.
8
The incidence of retinoblastoma.视网膜母细胞瘤的发病率。
Am J Ophthalmol. 1975 Aug;80(2):263-5. doi: 10.1016/0002-9394(75)90143-9.
9
Endophytic vs exophytic unilateral retinoblastoma: is there any real difference?内生型与外生型单侧视网膜母细胞瘤:是否存在实质差异?
J Pediatr Ophthalmol Strabismus. 1990 Sep-Oct;27(5):255-8. doi: 10.3928/0191-3913-19900901-10.
10
Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.视网膜母细胞瘤日本患者长期队列的生存和眼部保存。
BMC Pediatr. 2020 Jan 28;20(1):37. doi: 10.1186/s12887-020-1923-7.

引用本文的文献

1
Early detection of ocular abnormalities in a Chinese multicentre neonatal eye screening programme-1-year result.中国多中心新生儿眼病筛查项目中眼部异常的早期检测 - 1 年结果。
Acta Ophthalmol. 2021 May;99(3):e415-e422. doi: 10.1111/aos.14586. Epub 2020 Sep 15.
2
Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro.利用短发夹RNA(shRNA)下调基质金属蛋白酶-2/基质金属蛋白酶-9体外抑制人视网膜母细胞瘤细胞的进展
J Ophthalmol. 2020 May 13;2020:4912347. doi: 10.1155/2020/4912347. eCollection 2020.
3
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.
在视网膜母细胞瘤的体外模型中,抑制基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)可减少细胞迁移和血管生成。
BMC Cancer. 2017 Jun 20;17(1):434. doi: 10.1186/s12885-017-3418-y.
4
Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma.阿柏西普在视网膜母细胞瘤体外和体内模型中的疗效与安全性
J Exp Clin Cancer Res. 2016 Nov 4;35(1):171. doi: 10.1186/s13046-016-0451-7.
5
Adult onset retinoblastoma.成人型视网膜母细胞瘤
Indian J Ophthalmol. 2016 Jul;64(7):485-91. doi: 10.4103/0301-4738.190099.
6
Retinoblastoma in adults: a case report and literature review.成人视网膜母细胞瘤:一例报告及文献综述
J Ophthalmic Vis Res. 2014 Jul-Sep;9(3):388-91. doi: 10.4103/2008-322X.143382.
7
Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy.视网膜母细胞瘤的治疗负担与经济成本:诊断年龄及初始治疗选择的影响
Clin Ophthalmol. 2012;6:1601-6. doi: 10.2147/OPTH.S33094. Epub 2012 Oct 4.
8
Characteristics and clinical presentations of pediatric retinoblastoma in North-western Iran.伊朗西北部儿童视网膜母细胞瘤的特征与临床表现
Int J Ophthalmol. 2012;5(4):510-2. doi: 10.3980/j.issn.2222-3959.2012.04.20. Epub 2012 Aug 18.
9
Orbital exenteration: a review of 429 cases.眼眶内容剜除术:429例病例回顾
Int Ophthalmol. 1995;19(3):177-84. doi: 10.1007/BF00133735.
10
Parents with unilateral retinoblastoma: their affected children.
Br J Ophthalmol. 1996 Mar;80(3):197-9. doi: 10.1136/bjo.80.3.197.